1998•Drug and Therapeutics BulletinRequires access

Update on drugs for herpes zoster and genital herpes

Author information unavailable

Abstract

We reviewed the use of aciclovir (Zovirax - Glaxo Wellcome) 6 years ago.1 Since then, two more oral antiherpetic drugs have been licensed - famciclovir (Famvir - SmithKline Beecham) and valaciclovir (Valtrex - Glaxo Wellcome). Here we discuss their efficacy and safety, and review their place in the management of patients with herpes zoster (shingles) and genital herpes, comparing them with aciclovir.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Famciclovir, Valaciclovir, Genital herpes, Aciclovir, Shingles, Medicine, Dermatology, Herpes Genitalis